Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (431-440 of 625) with videos related to

Pageof 63
Sort By:
Rheumatology (Oxford, England)|August 16, 2024
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO studyFrancesco Muratore, Chiara Marvisi, Giulia Cassone, et al.
Clinical and Experimental Rheumatology|February 26, 2021
High-dose glucocorticoids pulse-therapy for beta-coronaviridae pneumonia: a systematic literature review and case-series of Coronavirus disease-2019Giovanni Dolci, Giulia Cassone, Francesco Venturelli, et al.
Joint Bone Spine|February 27, 2025
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritisAntonio Marchesoni, Pierluigi Macchioni, Giovanni Ciancio, et al.
Journal of Clinical Medicine|November 25, 2023
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian StudyMarco Sebastiani, Vincenzo Venerito, Elenia Laurino, et al.
Biomedicines|April 27, 2024
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern ItalyGeir Hetland, Magne Kristoffer Fagerhol, Mohammad Reza Mirlashari, et al.
Clinical and Experimental Rheumatology|October 31, 2024
A new instrument for the screening of psoriatic arthritis among psoriatic patientsGabriele De Marco, Antonio Marchesoni, Maria Manara, et al.
Rheumatology (Oxford, England)|April 15, 2021
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in ItalyStefania Spila Alegiani, Salvatore Crisafulli, Paolo Giorgi Rossi, et al.
Arthritis Care & Research|June 26, 2012
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicineElisa Gremese, Antonio Carletto, Melissa Padovan, et al.
Journal of Autoimmunity|March 1, 2024
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritisMartina Bonacini, Alessandro Rossi, Ilaria Ferrigno, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) studyIgnazio Olivieri, Paolo A Cortesi, Simona de Portu, et al.
Pageof 63

Showing results (431-440 of 625) with videos related to

Sort By:
Pageof 63
Rheumatology (Oxford, England)|August 16, 2024
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO studyFrancesco Muratore, Chiara Marvisi, Giulia Cassone, et al.
Clinical and Experimental Rheumatology|February 26, 2021
High-dose glucocorticoids pulse-therapy for beta-coronaviridae pneumonia: a systematic literature review and case-series of Coronavirus disease-2019Giovanni Dolci, Giulia Cassone, Francesco Venturelli, et al.
Joint Bone Spine|February 27, 2025
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritisAntonio Marchesoni, Pierluigi Macchioni, Giovanni Ciancio, et al.
Journal of Clinical Medicine|November 25, 2023
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian StudyMarco Sebastiani, Vincenzo Venerito, Elenia Laurino, et al.
Biomedicines|April 27, 2024
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern ItalyGeir Hetland, Magne Kristoffer Fagerhol, Mohammad Reza Mirlashari, et al.
Clinical and Experimental Rheumatology|October 31, 2024
A new instrument for the screening of psoriatic arthritis among psoriatic patientsGabriele De Marco, Antonio Marchesoni, Maria Manara, et al.
Rheumatology (Oxford, England)|April 15, 2021
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in ItalyStefania Spila Alegiani, Salvatore Crisafulli, Paolo Giorgi Rossi, et al.
Arthritis Care & Research|June 26, 2012
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicineElisa Gremese, Antonio Carletto, Melissa Padovan, et al.
Journal of Autoimmunity|March 1, 2024
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritisMartina Bonacini, Alessandro Rossi, Ilaria Ferrigno, et al.
Clinical and Experimental Rheumatology|December 4, 2015
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) studyIgnazio Olivieri, Paolo A Cortesi, Simona de Portu, et al.
Pageof 63